Lung Structure and Airway Diseases Flashcards
(17 cards)
describe the main structures in the respiratory tract
- conducting airways
- trachea: incomplete cartilage ring lined with smooth muscle and epithelium
- primary bronchus
- secondary bronchus - resistance airways
- bronchiole: airway with any cartilage
- terminal bronchiole - respiratory airways
- respiratory bronchiole
- alveolar duct
- alveolar sac
describe the structure of pulmonary blood vessels
describe the function of pulmonary blood vessels
Pulmonary arteries and veins
– carry blood to (arteries) and from (veins) the lungs
– pulmonary veins carry O2
– pulmonary arteries carry CO2
Bronchial arteries and veins
– supply blood to and drain from the airways
– bronchial arteries carry O2
– bronchial veins carry CO2
describe the structure of airway epithelium
- Lines the entire respiratory tract
- pseudostratified columnar structure
describe the function of airway epithelium
- Physical barrier
– prevents access to submucosa
* nerves, vascular tissue, airway
smooth muscle
- inhibits penetration of inhaled noxious substances - Housekeeping role
– cilia beat synchronously, propel mucus towards throat
– mucus and particulate matter continually cleared - Catabolic metabolism
– via cytochrome P450 system
– peptide degradation via neutral endopeptidase
– protects sensitive targets - nerves, muscle, glands - Anabolic metabolism
– synthesis of inhibitory mediators – PGE2 (prostoglandin E2)
– rich source of peptides – endothelin (growth factor)
– produces pro-inflammatory cytokines
describe the structure of nerves
describe the function of nerves
- Cholinergic (excitatory)
– dominant neural pathway
– major role in regulating airway smooth muscle tone
and mucus production - Noradrenergic (inhibitory)
– noradrenaline decrease smooth muscle tone
– no major role below main bronchi - Inhibitory nonadrenergic noncholinergic (iNANC)
– release nitric oxide (NO)
– innervates smooth muscle directly
– relaxation - Excitatory nonadrenergic noncholinergic (eNANC)
– release neuropeptides e.g., substance P, neurokinin A – increase airway tone, secretion of mucus and microvascular
leakage
describe the features of asthma
Chronic inflammatory disease of the airways characterised by bronchial obstruction and airflow limitation
- Characteristics
– shortness of breath, wheeze, tight chest, cough
– allergic, occupational, exercise-induced, aspirin
– mild, moderate, severe
Describe the asthma allergic response
– early phase response
* decrease in FEV1, peak at 30-40 min, resolves in 2-3 hrs
* mast cell-derived histamine and leukotrienes
– late phase response
* release of inflammatory mediators cause submucosal oedema, airway wall swelling, secretion of mucus
* epithelium remodelling, airway muscle hypertrophy/hyperplasia, subepithelial fibrosis
Describe Reversible bronchial obstruction
Caused by a range of endogenous mediators
– increasing airway smooth muscle tone
– increasing secretion of mucus
– shedding of the epithelium and accumulation of debris in airway lumen
– oedema and swelling of the submucosa
– airway smooth muscle hypertrophy (increase cell size) and hyperplasia (increase cell number)
– sub-epithelial fibrosis makes the airway thicker
Describe Airway hyperresponsiveness
Asthmatics are hyperresponsive to a range of unrelated stimuli
because:
* Airway narrowing
–increase airway smooth muscle force and/or mass
– microvascular leakage from post-capillary venules and resultant oedema
Airway narrowing causes changes to airway resistance
Describe Airway wall remodelling
- diluted blood vessels and leaking fluid are retained in the airway wall (oedema)
- an influx of inflammatory cells in airway e.g. eosinophil, mononuclear cells
- damaged epithelium can block the airway
- fibrin is laid down under epithelium making it thicker and stiffer
- Increase mucus blocks airway
- thicker cell size and more cells
describe the characteristic features of chronic obstructive pulmonary disease
- COPD = chronic bronchitis + emphysema
- Progressive degenerative disease causes death
– primary causes – tobacco smoking and air pollution - most important therapy is smoking cessation
- indoor air pollution – heating + cooking
- outdoor air pollution
- occupational dusts, chemicals, vapours, irritants, fumes
Chronic Bronchitis Features
- Inflammatory disease with irreversible airflow limitation
- Hypersecretion of bronchial mucus
– hypertrophy & hyperplasia of bronchial mucus-secreting cells
– chronic cough, excessive sputum - Secondary respiratory infections
– excessive mucus production
describe the mechanisms of action and therapeutic effects
of drugs used to treat chronic bronchitis
- Drugs provide symptom relief
– b2-adrenoceptor agonists -> relax smooth muscle
– muscarinic antagonists -> prevent bronchoconstriction
– glucocorticoids -> reduce inflam
– mucokine -> easier to cough up
– antibiotics (secondary infections) - Selective phosphodiesterase IV inhibitor (roflumilast)
- increases the break down of CAMP increasing the relaxation of airway smooth muscle
Emphysema
- Degenerative, peripheral lung disease
- Involves destruction of alveolar membranes
– causes severe impairment of- oxygen delivery
- carbon dioxide clearance
- Often associated with smoking and
chronic bronchitis